Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action

Journal of Psychiatric Research

Volumn 31, Issue 2, 1997, Pages 219-232

  Sanyal, Suparna ^a   Van Tol, Hubert H M ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; NEUROLEPTIC AGENT;

BINDING AFFINITY; DOPAMINERGIC SYSTEM; DRUG RECEPTOR BINDING; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

EID: 0030752950     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(96)00039-8     Document Type: Review

References (82)

1. 2 receptor to inhibiti0on of adenylyl cyclase and prolactin secretion. The Journal of Biological Chemistry, 265, 2098-2104.
2. 4 receptor repeat: analysis of different native and mutant forms of the human and rat genes. Molecular Pharmacology, 46, 364-373.
3. 4 receptor variants. Journal of Neurochemistry, 65, 1157-1165.
4. Barr, C. L., Kennedy, J. L., Lichter, J. B., Van Tol, H. H. M., Wetterberg, L., Livak, K. J., Kidd, K. K. 1993) Alleles at the dopamine D4 receptor locus do not contribute to the genetic susceptibility to schizophrenia in a large Swedish kindred. American Journal of Medical Genetics (Neuropsychiatric Genetics), 48(, 218-222.
5. Bleich, A., Brown, S. L., Cahn, R., & van Praag, H. M. (1988). The role of serotonin in schizophrenia. Schizophrenia Bulletin, 14, 297-315.
6. Bouvier, C., Bunzow, J. R., Guan, H.-C., Unteutsch, A., Civelli, O., Grandy, D. K., & Van Tol, H. H. M. (1995). Functional characterization of the human dopamine D4.2 receptor using vaccinia virus as an expression system. European Journal of Pharmacology (Molecular Pharmacology Section), 290, 11-17.
7. 4 receptor gene in psychotic patients. Biological Psychiatry, 34, 459-464.
8. 4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells. The Journal of Biological Chemistry, 269, 11813-11819.
9. Civelli, O., Bunzow, J. R., & Grandy, D. K. (1993). Molecular diversity of the dopamine receptors. Annual Review of Pharmacology and Toxicology, 32, 281-307.
10. Coon, H., Byerley, W., Holik, J., Hoff, M., Myles-Worsley, M., Lannfelt, L., Sokoloff, P., Schwartz, J.-C., Waldo, M., Freedman, R., & Plaetke, R. (1993). Linkage analysis of schizophrenia with five dopamine receptor genes in nine pedigrees. American Journal of Human Genetics, 52, 327-334.
11. Coward, D. M. (1992). General pharmacology of clozapine. British Journal of Psychiatry, 160, 5-11.
12. Creese, I., Burt, D. R., & Snyder, S. H. (1976). Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science, 192, 481-483.
13. Crocq, M. A., Mant, R., Asherson, P., Williams, J., Hode, Y., Mayerova, A., Collier, D., Lannfelt, L., Sokoloff, P., & Schwartz, J.-C. (1992). Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. Journal of Medical Genetics, 29, 858-860.
14. Di Bella, D., Catalano, M., Strukel, A., Nobile, M., Novelli, E., & Smeraldi, E. (1994). Distribution of the MscI polymorphism of the dopamine D3 receptor in an Italian psychotic population. Psychiatric Genetics, 4, 29-42.
15. Elsholtz, H. P., Lew, A. M., Albert, P. R., & Sundmark, V. C. (1991). Inhibitory control of prolactin and Pit-1 gene promoters by dopamine. Journal of Biological Chemistry, 266, 22919-22925.
16. 11C]raclopride. Archives of General Psychiatry, 47, 213-219.
17. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation of extrapyramidal side effects. Archives of General Psychiatry, 49, 538-544.
18. 4 dopamine receptor (DRD4) maps to distal 11p close to HRAS. Genomics, 13, 208-210.
19. Gottesman, I. I. (1991). Is schizophrenia inherited genetically? In Schizophrenia Genesis. The origin of madness (pp. 82-103). New York: W. H. Freeman and Company.
20. 2 antagonistic properties. Journal of Pharmacological and Experimental Therapeutics, 244, 685-693.
21. Kane, J., Honigffeld, G., Singer, J., & Meltzer, H. (1988). Clozapine for the treatment-resistant schizophrenic. Archives of General Psychiatry, 45, 789-796.
22. Kane, J. M., & Freeman, H. L. (1994). Towards more effective antipsychotic treatment. British Journal of Psychiatry, 165(25), 22-31.
23. 4 receptor variants and schizophrenia. American Journal of Human Genetics, Abstract, 1437.
24. Kerwin, R. W. (1994). The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research. British Journal of Psychiatry, 164, 141-148.
25. Kety, S. S., & Ingraham, L. J. (1992). Genetic transmission and improved diagnosis of schizophrenia from pedigrees of adoptees. Journal of Psychiatric Research, 26, 247-255.
26. 4 dopamine receptors determined in transfected cell lines. Clinical Neuropharmacology, 18, S25-S33.
27. 4 (DRD4) gene. Human Molecular Genetics, 2, 767-773.
28. Lieberman, J. A., Kane, J. M., & Alvir, J. (1987). Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacology, 91, 415-433.
29. Lieberman, J. A., Johns, C., Pollack, S., Masiar, S., Bookstein, P., Cooper, T., Iadorola, M. & Kane, J. M. (1991). Biochemical effects of clozapine in cerebrospinal fluid of patients with schizophrenia. In C. A. Tamminga & S. C. Schulz (Eds), Advances in Neuropsychiatry and Psychopharmacology, Volume 1: Schizophrenica Research (pp. 341-349). New York: Raven Press.
30. VAL194GLY, is insensitive to dopamine and clozapine. Report of a homozygous individual. American Journal of Medical Genetics (in press).
31. 4 dopamine receptor gene variant in an Italian schizophrenia kindred. Archives of General Psychiatry, 51, 288-292.
32. 4 dopamine receptor mRNAs in the rat brain: an in situ hybridization study. Society of Neuroscience (Abstract), 17, 599.
33. Mant, R., Williams, J., Asherson, P., Parfitt, E., McGuffin, P., & Owen, M. J. (1994). Relationship between homozygosity at the D3 receptor gene and schizophrenia. American Journal of Medical Genetics, 54, 21-26.
34. Matsumoto, M., Hidaka, K., Tada, S., Tasaki, Y., & Yamaguchi, T. (1995). Full-length cDNA cloning and distribution of human dopamine D4 receptor. Molecular Brain Research, 29, 157-162.
35. McGuffin, P. (1988). Genetics of schizophrenia. In P. Bebbington & P. McGuffin (Eds), Schizophrenia the Major Issue (pp. 107-176). London: Heineman Medical.
36. Meador-Woodruff, J. H., Grandy, D. K., Van Tol, H. H. M., Damask, S. P., Little, K. Y., Civelli, O., & Watson, S. J. (1994). Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychoparmacology, 10, 239-248.
37. Meador-Woodruff, J. H., Mansour, A., Saul, J. & Watson, S. J. (1994b). Neuranatomical distribution of dopamine receptor messenger RNAs. In H. B. Niznik (Ed.), Dopamine Receptor and Transporters: Pharmacology, Structure, and Function (pp. 401-415). New York: Marcel Dekker, Inc.
38. Mei, Y. A., Griffon, N., Buquet, C., Martres, M. P., Vaudry, H., Schwartz, J. C., Sokoloff, P., & Cazin, L. (1995). Activation of dopamine D4 receptor inhibits an L-type calcium current in cerebellar granule cells. Neuroscience, 68, 107-116.
39. Meltzer, H. Y. (1992). The importance of serotonin-dopamine interactions in the action of clozapine. British Journal of Psychiatry, 160, 22-29.
40. 4 dopamine receptors in postmortem striatum from patients with schizophrenia. The Journal of Neuroscience, 15, 2186-2191.
41. 3 receptor gene. Human Genetics, 92, 336-338.
42. 4 receptor polymorphism and schizophrenia. The Lancet, 341, 689-690.
43. 4 receptor gene loci in four Japanese pedigrees. Psychiatry Research, 52, 149-157.
44. 3 receptor gene locus. American Journal of Medical Genetics, 54, 264-267.
45. 3 receptor gene. Journal of Medical Genetics, 29, 858-860.
46. 11C]N-methylspiperone. Psychiatry Research: Neuroimaging, 61, 67-83.
47. 4 receptor gene: frequent occurrence of a null allele and observation of homozygosity. Human Molecular Genetics, 3, 2207-2212.
48. Owen, R. R., Gutierrez-Esteinou, R., Hsiao, J., Hadd, K., Benkelfat, C., Lawlor, B. A., Murphy, D. L., & Pickar, D. (1993). Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia. Archives of General Psychiatry, 50, 636-644.
49. 4 dopamine receptor gene maps to 11p proximal to HRAS. Genomics, 18, 161-163.
50. 4 dopamine receptor (DRD4) gene. Human Genetics, 93, 719.
51. 4 Dopamine receptor (DRD4) gene. Human Genetics, 93, 719.
52. Pickar, D., Owen, R. R., Litman, R. E., Konicki, P. E., Gutierrez, R., & Rapaport, M. H. (1992). Clinical and biological response to clozapine in patients with schizophrenia. Crossover comparison with Fluphenazine. Archives of General Psychiatry, 49, 345-352.
53. Pilowsky, L., Costa, D. C., Ell, P. J., Murray, R. M., Verhoeff, N. P., & Kerwin, R. W. (1992). Clozapine, single photon emission tomography and D2 dopamine receptor blockade hypothesis of schizophrenia. Lancet, 340, 199-202.
54. Rao, P. A., Pickar, D., Gejman, P. V., Ram, A., Gershon, E. S., & Gelernter, J. (1994). Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine. Archives of General Psychiatry, 51, 912-917.
55. Reynolds, G. P., & Mason, S. L. (1995). Absence of detectable striatal dopamine D4 receptors in drug-treated schizophrenia. European Journal of Pharmacology, 281, R5-R6.
56. Sabate, O., Campion, D., d'Amato, T., Martres, M. P., Sokoloff, P., Giros, B., Leboyer, M., Jay, M., Guedj, F., Thibaut, F., Dollfus, S., Preterre, P., Petit, M., Babron, M.-C., Watsman, G., Mallet, J., & Schwartz, J. C. (1994). Failure to find evidence for linkage or association between the dopamine D2 receptor gene and schizophrenia. American Journal of Pschiatry, 151, 107-111.
57. Saha, N., Tsoi, W. F., Low, P. S., Basair, J., & Tay, J. S. (1994). Lack of association of the dopamine D3 receptor gene polymorphism (Ball) in Chinese schizophrenic males. Psychiatriic Genetics, 4, 201-204.
58. Schwartz, J. T., & Brotman, A. W. (1992). A clinical guide to antipsychotic drugs. Drugs, 44, 981-992.
59. 4 receptors by two-fold in rats. European Journal of Pharmacology (Molecular Pharmacology Section), 289, 67-72.
60. 4 dopamine receptors. British Journal of Pharmacology, 112, 728-734.
61. Seeman, P., Chau-Wong, M., Tedesco, J., & Wong, K. (1975). Brain receptors for antipsychotic drugs and dopamine: Direct binding assays. Proceedings of the National Academy of Sciences, U.S.A., 72, 4376-4380.
62. Seeman, P. (1987). Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse, 1, 133-152.
63. Seeman, P., Bzowej, N. H., Guan, H.-C., Bergeron, C., Reynolds, G. P., Bird, E. D., Riederer, P., Jellinger, K., & Tourtellotte, W. W. (1987). Human brain D1 and D2 dopamine receptors in schizophrenia. Alzheimer's, Parkinson's and Huntington's diseases. Neuropsychopharmacology, 1, 5-15.
64. 3H]raclopride: implication for positron emission tomography of the human brain. Synapse, 3, 96-97.
65. 2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. Proceedings of the National Academy of Sciences, U.S.A., 86, 10156-10160.
66. 4. Neuropsychopharmacology, 7, 261-284.
67. 4 receptors elevated in schizophrenia. Nature, 365, 441-445.
68. GLYCINE194, in Africans, but not in Caucasians: no association with schizophrenia. American Journal of Medical Genetics (Neuropsychiatric Genetics), 54(1994), 384-390.
69. Seeman, P. & Van Tol, H. H. M. (1995a). Deriving the therapeutic concentrations for clozapine and haloperidol: the apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand. European Journal of Pharmacology (Molecular Pharmacology Section) (in press).
70. 3H]Nemonapride. Journal of Neurochemistry, 64, 1-3.
71. Seeman, P. & Van Tol, H. H. M. (1995c). Schizophrenia: elevation of dopamine D4-like sites. Therapeutic role of dopamine D4 receptors for clozapine. Journal of Neurochemistry (in press).
72. 4 receptor subtypes and response to clozapine. The Lancet, 341, 116.
73. Shaikh, S., Gill, M., Owen, M., Asherson, P., McGuffin, P., Nanko, S., Murray, R. M., & Collier, D. A. (1994). Failure to find linkage between a functional polymorphism in the dopamine D4 receptor gene and schizophrenia. American Journal of Medical Genetics (Neuropsychiatric Genetics), 54, 8-11.
74. 4 receptor variants in unrelated schizophrenic cases and controls. American Journal of Medical Genetics, 48, 90-93.
75. Spiegel, A. M., Shenker, A., & Weinstein, L. S. (1992). Receptor-effector coupling by G proteins: implications for normal and abnormal signal transduction. Endocrine Reviews, 13, 536-565.
76. 4 receptors in postmortem caudate nucleus of subjects with schizophrenia. Society of Neuroscience Abstract, 20, 912.
77. Swarzenski, B. C., Tang, L., Oh, Y. J., O'Malley, K. L., & Todd, R. D. (1994). Morphogenic potentials of D2, D3, and D4 dopamine receptors in transfected neuronal cell lines. Proceedings of the National Academy of Sciences, U.S.A., 91, 649-653.
78. Tang, L., Todd, R. D., Heller, A., O'Malley, K. L. (1994) Pharmacological and functional characterization of D2 dopamine, D3 dopamine and D4 dopamine receptors in fibroblast and dopaminergic cell-lines. Journal of Pharmacological and Experimental Therapeutics, 268, 495-502.
79. 4 receptor mRNA levels in rat brain and pituitary during aging. Neurobiology of Aging, 15, 713-719.
80. 4 receptor variants in the human population. Nature, 358, 149-152.
81. 4 receptor with high affinity for the antipsychotic clozapine. Nature, 350, 610-614.
82. 2 dopamine receptors in drug-naive schizophrenics. Science, 234, 1558-1563.